Artificial Intelligence for Real-time Detection and Monitoring of Colorectal Polyps

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) (Other)
Overall Status
Recruiting
CT.gov ID
NCT04586556
Collaborator
(none)
600
3
1
22.4
200
8.9

Study Details

Study Description

Brief Summary

The investigators hypothesize that the clinical implementation of a deep learning AI system is an optimal tool to monitor, audit and improve the detection and classification of polyps and other anatomical landmarks during colonoscopy. The objectives of this study are to generate preliminary data to evaluate the effectiveness of AI-assisted colonoscopy on: a) the rate of detection of adenomas; b) the automatic detection of the anatomical landmarks (i.e., ileocecal valve and appendiceal orifice).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Polyps detection by Artificial Intelligence
N/A

Detailed Description

In this trial, the investigators aim to evaluate the followings:
  1. the accuracy of automatic detection of important anatomical landmarks (i.e., ileocecal valve, appendiceal orifice);

  2. the accuracy of automatic detection of polyps/adenomas (PDR/ADR);

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Artificial Intelligence for Real-time Detection and Monitoring of Colorectal Polyps
Actual Study Start Date :
Dec 18, 2020
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Artificial intelligence for real-time detection and monitoring of colorectal polyps

A standard colonoscopy will be performed according to the standard of routine care. All optically diagnosed polyps will be removed and sent to the CHUM pathology laboratory for histopathological evaluation according to institutional standards. The AI system will capture video of the procedure in real time, and provide additional information on the detection of polyps, follow-up and prediction of pathology. The full-length colonoscopy videos will be annotated for the exact time of the identification of the anatomical landmarks, polyps, also for polyp- and procedural-related characteristics.

Diagnostic Test: Polyps detection by Artificial Intelligence
The AI system will capture the live video of the procedure and the AI feedback (polyp detection, tracking, and pathology prediction) will be shown on a second screen installed next to the regular endoscopy screen. Screen A will show the regular endoscopy image and screen B will show the regular endoscopy image together with the areas that might harbor a polyp or the information to predict pathology

Outcome Measures

Primary Outcome Measures

  1. Number of polyps detected [Day 1]

    Efficacy of AI assisted colonoscopy to detect the proportion of patients with at least 1 polyp. Polyp detection rate with an AI.

  2. Evaluation of the automatic report of the colonoscopy quality indicators [Day 1]

    Compare of the automatic detection of the ileocecal valve, appendiceal orifice, and the automatic calculation of the withdrawal time with manual detection

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria :
  • Signed informed consent

  • Age 45-80 years

  • Indication to undergo a lower GI endoscopy.

Exclusion Criteria :
  • Coagulopathy

  • Poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class >3

  • Emergency colonoscopies

  • Hospitalized patients

  • Known inflammatory bowel disease (IBD)

  • Patients currently in the emergency room

Contacts and Locations

Locations

Site City State Country Postal Code
1 Université de Montréal Montréal Quebec Canada QC H3T 1J4
2 Centre Hospitalier Universitaire de Montréal Montréal Quebec Canada
3 IHU Strasbourg Strasbourg France 67000

Sponsors and Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre hospitalier de l'Université de Montréal (CHUM)
ClinicalTrials.gov Identifier:
NCT04586556
Other Study ID Numbers:
  • 20.198
First Posted:
Oct 14, 2020
Last Update Posted:
Mar 11, 2022
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre hospitalier de l'Université de Montréal (CHUM)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 11, 2022